KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Net Income (2016 - 2025)

Fulgent Genetics' Net Income history spans 11 years, with the latest figure at $32.5 million for Q4 2025.

  • For Q4 2025, Net Income fell 20.0% year-over-year to $32.5 million; the TTM value through Dec 2025 reached -$5.5 million, down 284.12%, while the annual FY2025 figure was -$8.3 million, 376.18% down from the prior year.
  • Net Income for Q4 2025 was $32.5 million at Fulgent Genetics, up from -$6.8 million in the prior quarter.
  • Across five years, Net Income topped out at $200.7 million in Q1 2021 and bottomed at -$213.5 million in Q4 2022.
  • The 5-year median for Net Income is -$7.9 million (2024), against an average of $13.9 million.
  • The largest annual shift saw Net Income skyrocketed 11856.94% in 2021 before it crashed 1100.74% in 2023.
  • A 5-year view of Net Income shows it stood at $103.7 million in 2021, then tumbled by 305.91% to -$213.5 million in 2022, then surged by 37.07% to -$134.3 million in 2023, then soared by 130.23% to $40.6 million in 2024, then decreased by 20.0% to $32.5 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Net Income are $32.5 million (Q4 2025), -$6.8 million (Q3 2025), and -$19.3 million (Q2 2025).